Medicine and Dentistry
Neoplasm
83%
Bladder Cancer
72%
Metastatic Carcinoma
54%
Protein P53
49%
Recurrent Disease
47%
Lymph Node
45%
Immunohistochemistry
44%
Circulating Tumor Cell
43%
Breast Cancer
42%
Bladder
41%
Diseases
39%
Prostate Cancer
36%
Transitional Cell Carcinoma
33%
Cystectomy
31%
Malignant Neoplasm
27%
Antigen Retrieval
25%
Biological Marker
22%
Tumor Cell
19%
Overall Survival
19%
Micrometastasis
18%
Bladder Tumor
17%
Cancer Cell
17%
Monoclonal Antibody
16%
Tumor Progression
14%
Formaldehyde
14%
Lymph Node Metastasis
13%
Breast Carcinoma
13%
Invasive Bladder Cancer
12%
Pathologist
11%
P21
10%
Cancer Staging
10%
Epithelial Cell
10%
Tumor Angiogenesis
9%
Molecular Marker
9%
Prostate Specific Antigen
9%
Human Monoclonal Antibody
9%
Cancer
9%
Prostatectomy
9%
Clinical Trial
8%
Adjuvant Therapy
8%
Urothelial Cancer
8%
Diagnosis
8%
Prostate Carcinoma
8%
In Vitro
8%
Lung Cancer
8%
Primary Tumor
8%
Cancer Diagnosis
7%
Microfiltration
7%
Cancer Stem Cell
7%
Carcinoma
7%
Keyphrases
Bladder Cancer
100%
Tumor
74%
Circulating Tumor Cells
69%
Immunohistochemistry
49%
Antigen Retrieval
43%
Prostate Cancer
30%
Overall Survival
29%
Monoclonal Antibody
28%
Tumor Cells
28%
Upper Tract Urothelial Carcinoma
25%
Bone Marrow
24%
Lymph Node
23%
Radical Cystectomy
22%
Bladder Tumor
22%
Tumor Progression
19%
Occult Metastasis
19%
Retrieval Methods
18%
Microfilter
17%
Prostate-specific Antigen
17%
Breast Cancer
17%
Metastasis
16%
Bladder Transitional Cell Carcinoma
15%
Invasive Bladder Cancer
15%
Pathological Stage
15%
Occult
15%
Formalin-fixed Paraffin-embedded Tissue
15%
Recurrence Rate
14%
Tumor Angiogenesis
14%
Cystectomy
14%
Micrometastasis
14%
Primary Tumor
13%
Lymph Node Positive
13%
Disseminated Tumor Cells
12%
Tumor Stage
12%
Label-free
12%
Outcome Prediction
12%
Clinical Significance
12%
Cancer Cells
11%
Prognostic Marker
11%
P53 Gene
11%
Molecular Alterations
11%
Cancer Management
11%
Molecular Markers
11%
P53 Protein
10%
Metastatic Breast Cancer
10%
Paraffin Section
10%
Breast Cancer Cells
10%
Hazard Ratio
10%
Immunohistochemical Staining
10%
Cancer Patients
10%